In the News

September 12, 2017

California bill that would require drug makers to report and justify price hikes took a big step toward reality on Monday night. The state Assembly overwhelmingly passed the legislation and it now goes to the Senate for approval, which legislative sources say may occur as soon as today.

September 11, 2017

The California State Assembly on Monday overwhelmingly approved Senate Bill 17, controversial legislation that could soon become the nation’s most comprehensive law aimed at shining a light on prescription drug prices.

The 58-10 vote easily overcame the 41 votes needed to pass, though an earlier vote late Monday afternoon had come up short at 31-6. At that point, the bill was put on call and the voting roll was kept open for less than an hour until the final vote was called.

September 11, 2017

The final week for the state legislative year opens Monday morning and it’s the last chance this year for California legislators to pass new laws.

September 7, 2017

Californians now pay more for their prescription drugs than they do for their doctors. The state spent a whopping $4 billion on drugs in 2015, and pharmaceutical companies are pushing another 12 percent increase in 2017.

The skyrocketing costs are unsustainable. The Legislature has to pass state Sen. Ed Hernandez’ SB 17 and force drug makers to provide information about how they price their products.

September 4, 2017

Assemblyman Chad Mayes, Assemblyman Eduardo Garcia and Sen. Jeff Stone – who all represent parts of the Coachella Valley in the Legislature – play a crucial role in the fight against cancer by passing laws that help reduce the toll of cancer, which will claim nearly 60,000 lives in California this year alone.

If state lawmakers take critical preventive measures now, they could keep thousands of people from hearing the words “You have cancer” in the future.

August 29, 2017

In response to some health insurers leaving the individual market, state lawmakers are considering a bill that would ensure continuity of care for people with complex health conditions. The measure would require a new insurance firm to cover the providers of qualifying patients, even if the provider isn't in the insurer's network. The insurance industry says the bill would provide a blank check for out-of-network care in some instances.

July 24, 2017

Led by their trade group, the Pharmaceutical Research and Manufacturers of America, drugmakers insist that they have consumers’ best interests at heart and warn that over-regulation would hamper their ability to deliver life-saving drugs.

July 24, 2017

After years of failed efforts, the California Legislature may finally pass a bill that responds to the problem of rising prescription drug costs. But temper your enthusiasm: Though this measure (SB 17) has been fiercely resisted by the pharmaceutical industry, it wouldn’t actually stop manufacturers from raising their prices as high as they think the market will bear. It would just make them reveal more about the cost and value of their drugs as they do so.